BiOptix Announces Additional $1.4M in Funding to Aid in Commercialization and Working Capital Needs

Boulder, Colorado, August 13, 2014 — BiOptix announced today an additional $1.4M financing from existing investors. The funds will be used to expand sales and marketing and ramp up manufacturing to meet growing customer demand.

Rick Whitcomb, President and CEO of BiOptix, noted: “This latest increase in capital shows that our investors are confident in our plan and our team, and that BiOptix is on a solid path to commercial success.” BiOptix continues to see opportunity in the label-free marketplace, which is looking for a high quality, high performance SPR instrument at a reasonable price. “We are making great inroads in the marketplace, and this infusion of capital will aid our efforts to reach as many scientific researchers as possible,” commented Whitcomb.